Willem A. Nolen, MD, PhD

DSM-IV vs DSM-5: Effect on Bipolar Disorder Diagnosis

October 29, 2019

Since 2013, when DSM-5 was published, a third of the patients previously diagnosed with bipolar disorder no longer qualify as having the disorder. So what does this say about...

Mette U. Fredskild, Jim Mintz, Mark A. Frye, et al

Original Research

Age at Onset of Bipolar Disorder

October 26, 2016

Read this article to learn whether age of onset of bipolar disorder or psychiatric illness is due to demographics or family psychiatric history.

Robert M. Post, Lori L. Altshuler, Ralph Kupka, et al

Original Research

Evidence of a Cohort Effect in Bipolar

August 24, 2016

Read an article exploring further evidence of the cohort effect for earlier age at onset of bipolar disorder and greater burden of psychiatric disorders.

Robert M. Post, Ralph Kupka, Paul E. Keck Jr, et al

Article

Illness Progression as a Function of Independent and Accumulating Poor Prognosis Factors in Outpatients With Bipolar Disorder in the United States

December 18, 2014

Many patients with bipolar disorder in the United States experience a deteriorating course of illness despite naturalistic treatment in the community. In this study, Post and colleagues explored this...

Robert M. Post, Lori L. Altshuler, Gabriele S. Leverich, et al

Original Research

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

March 20, 2012

Robert M. Post, Gabriele S. Leverich, Lori L. Altshuler, et al

Original Research

Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

November 15, 2011

Richard H. Weisler, Willem A. Nolen, Anders Neijber, et al

Original Research

Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: the Netherlands Study of Depression and Anxiety (NESDA)

January 25, 2011

Femke Lamers, Patricia van Oppen, Hannie C. Comijs, et al

Original Research

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder

September 15, 2010

Robert M. Post, Lori L. Altshuler, Mark A. Frye, et al

Original Research

Early-Onset Bipolar Age & Treatment Delay

July 15, 2010

Read an article examining the influence of age at early onset bipolar disorder and the delay in time to first treatment on morbidity in adulthood.

Robert M. Post, Gabriele S. Leverich, Ralph W. Kupka, et al

Original Research

Identifying Depressive Subtypes in a Large Cohort Study: Results From the Netherlands Study of Depression and Anxiety (NESDA)

July 13, 2010

Femke Lamers, Peter de Jonge, Willem A. Nolen, et al

Original Research

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial

December 30, 2009

Marc L. M. van der Loos, Paul G. H. Mulder, Erwin G. Th. M. Hartong, et al

Original Research

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

April 7, 2009

Lori L. Altshuler, Robert M. Post, Gerhard Hellemann, et al

DSM-IV vs DSM-5: Effect on Bipolar Disorder Diagnosis

Age at Onset of Bipolar Disorder

Evidence of a Cohort Effect in Bipolar

Illness Progression as a Function of Independent and Accumulating Poor Prognosis Factors in Outpatients With Bipolar Disorder in the United States

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: the Netherlands Study of Depression and Anxiety (NESDA)

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder

Early-Onset Bipolar Age & Treatment Delay

Identifying Depressive Subtypes in a Large Cohort Study: Results From the Netherlands Study of Depression and Anxiety (NESDA)

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

ELSEWHERE:

FOLLOW US:

Willem A. Nolen, MD, PhD

DSM-IV vs DSM-5: Effect on Bipolar Disorder Diagnosis

Age at Onset of Bipolar Disorder

Evidence of a Cohort Effect in Bipolar

Illness Progression as a Function of Independent and Accumulating Poor Prognosis Factors in Outpatients With Bipolar Disorder in the United States

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: the Netherlands Study of Depression and Anxiety (NESDA)

Complexity of Pharmacologic Treatment Required for Sustained Improvement in Outpatients With Bipolar Disorder

Early-Onset Bipolar Age & Treatment Delay

Identifying Depressive Subtypes in a Large Cohort Study: Results From the Netherlands Study of Depression and Anxiety (NESDA)

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles